Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet-activating factor (PAF) is a potent phospholipid mediator involved in numerous physiological and pathological processes, particularly those related to inflammation, thrombosis, and immune responses. It acts as both an intercellular messenger and intracellular signal transducer, playing critical roles in cardiovascular physiology/pathophysiology and contributing to diseases like atherosclerosis and asthma. PAF exerts its effects by binding to the Platelet Activating Factor Receptor (PAFR).
PAF exerts its effects by binding to the Platelet Activating Factor Receptor (PAFR), a G-protein coupled receptor, leading to downstream signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet Activating Factor (PAF).